Skip to main content
. 2022 Mar 28;34(3):276–286. doi: 10.4103/tcmj.tcmj_318_21

Table 1.

Examples of inhibitory peptides targeting spike protein - angiotensin-converting enzyme 2 interactions

Sequences (names) Sequence source
21IEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNIT55 (inhibitor 1) ACE2 [68]
21IEEQAKTFLDNFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEI88 ACE2 [68]
349WDLGKGDFR357(inhibitor 2)
21IEEQAKTFLDNFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQALTVKLQLQALQQNGS105 ACE2 [68]
323MTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFRILMCT362 (inhibitor 3)
21IEEQAKTFLDNFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQALTVKL95 ACE2 [68]
335DPGNVQKAVCHPTAWDLGKGDFRILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGF400 (inhibitor 4)
DEDLEELERLYRKAEEVAKEAKDASRRGDDERAKEQMERAMRLFDQVFELAQELQEKQTDGNRQKATHLDKAVKEAADELYQRVR (AHB1) de Novo [70]
ELEEQVMHVLDQVSELAHELLHKLTGEELERAAYFNWWATEMMLELIKSDDEREIREIEEEARRILEHLEELARK (AHB2) de Novo [70]
DKEWILQKIYEIMRLLDELGHAEASMRVSDLIYEFMKKGDERLLEEAERLLEEVER (LCB1) de Novo [70]
SDDEDSVRYLLYMAELRYEQGNPEKAKKILEMAEFIAKRNNNEELERLVREVKKRL (LCB2) de Novo [70]
NDDELHMLMTDLVYEALHFAKDEEIKKRVFQLFELADKAYKNNDRQKLEKVVEELKELLERLLS (LCB3) de Novo [70]
QREKRLKQLEMLLEYAIERNDPYLMFDVAVEMLRLAEENNDERIIERAKRILEEYE (LCB4) de Novo [70]
SLEELKEQVKELKKELSPEMRRLIEEALRFLEEGNPAMAMMVLSDLVYQLGDPRVIDLYMLVTKT (LCB5) de Novo [70]
DREQRLVRFLVRLASKFNLSPEQILQLFEVLEELLERGVSEEEIRKQLEEVAKELG (LCB6) de Novo [70]
DDDIRYLIYMAKLRLEQGNPEEAEKVLEMARFLAERLGMEELLKEVRELLRKIEELR (LCB7) de Novo [70]
PIIELLREAKEKNDEFAISDALYLVNELLQRTGDPRLEEVLYLIWRALKEKDPRLLDRAIELFER (LCB8) de Novo [70]
SALEEQLKTFLDKFMHELEDLLYQLAL (P8) Derived* [71]
SALEEQYKTFLDKFM HELEDLLYQLSL (P9) Derived* [71]
SALEEQYKTFLDKFMHELEDLLYQLAL (P10) Derived* [71]
19STIEEQAKTFLDKFNHEAEDLFYQSSL45 ACE2 WT [72]
24QAKTFLDKFNHEAEDLFYQSS44GLGKGDFR ACE2 WT [72]
QVKYFLDKFNHEAEDRDYQSSL ACE2 MT [72]
PFLEKLLHEAEDLLYQLELA ACE2 MT [72]
PFLEKLLHEcdEDCLYQLELA ACE2 MT [72]
483VEGFNCYFPLQSYGFQPTNGVGY505 RBD WT [72]

*Peptides derived from ACE2 sequence“19STIEEQAKTFLDKFNHEAEDLFYQSSL45”. WT: Wild type, MT: Mutant, cd: D-cysteine, ACE2: Angiotensin-converting enzyme 2, RBD: Receptor-binding domain